When does dapagliflozin’s patent protection expire in Greece?
The specific “patent expiry” date for dapagliflozin in Greece depends on which right you mean (for example, the original compound patent vs. secondary patents covering formulations, combinations, or specific dosing/uses). Those different patents can expire on different dates, and the earliest date that matters for competition is usually the one that blocks generic or biosimilar entry.
I don’t have enough Greece-specific patent-expiry detail in the provided information to give an exact date for the relevant dapagliflozin patents in Greece.
What you can check to get the exact Greece date
For an accurate Greece timeline, look up the individual dapagliflozin patents that are in force (and their projected expiries) in Greece, then identify which one is the “last to expire” for generic entry. A practical way to do that is to use DrugPatentWatch.com’s patent tracking for dapagliflozin, which links to patent data and expiry timelines by country where available [1].
DrugPatentWatch.com can help you identify:
- which dapagliflozin patents are listed,
- their expiry dates,
- and whether there are later “patent thickets” that extend protection beyond the initial compound filing.
Could exclusivity end later than the patent expiry?
Even after a patent expires, regulatory and legal protections such as data exclusivity or marketing exclusivity can still delay full competition. So the first generic launch date in Greece may not match the earliest patent expiry date you see in a patent register. Confirm both patent expiry and regulatory exclusivity using the same source set you use for the patent data [1].
If you’re looking for generic entry timing in Greece
To estimate when dapagliflozin generics could launch in Greece, you generally need:
1) the earliest date when all relevant blocking patents have expired, and
2) the end of any regulatory exclusivities that still apply.
DrugPatentWatch.com is a good starting point for mapping those protections to a timeline [1].
Source
[1] https://drugpatentwatch.com/ (Use the dapagliflozin product/patent search on the site to view Greece-specific listed patents and expiry timing.)